Background: Phytophthora capsici root rot (PRR) is a disastrous disease in peppers (Capsicum spp.) caused by soilborne oomycete with typical symptoms of necrosis and constriction at the basal stem and consequent plant wilting.

 

Most studies on the QTL mapping of P. capsici resistance suggested a consensus broad-spectrum QTL on chromosome 5 named Pc.5.1 regardless of P. capsici isolates and resistant resources. In addition, all these reports proposed NBS-ARC domain genes as candidate genes controlling resistance.

Results: We screened out 10 PRR-resistant resources from 160 Capsicum germplasm and inspected the response of locus Pc.5.1 and NBS-ARC genes during P. capsici infection by comparing the root transcriptomes of resistant pepper 305R and susceptible pepper 372S.

 

To dissect the structure of Pc.5.1, we anchored genetic markers onto pepper genomic sequence and made an extended Pc5.1 (Ext-Pc5.1) located at 8.35 Mb-38.13 Mb on chromosome 5 which covered all Pc5.1 reported in publications.

A total of 571 NBS-ARC genes were mined from the genome of pepper CM334 and 34 genes were significantly affected by P. capsici infection in either 305R or 372S. Only 5 inducible NBS-ARC genes had LRR domains and none of them was positioned at Ext-Pc5.1. Ext-Pc5.1 did show strong response to P. capsici infection and there were a total of 44 differentially expressed genes (DEGs), but no candidate genes proposed by previous publications was included. Snakin-1 (SN1), a well-known antimicrobial peptide gene located at Pc5.1, was significantly decreased in 372S but not in 305R.

Moreover, there was an impressive upregulation of sugar pathway genes in 305R, which was confirmed by metabolite analysis of roots. The biological processes of histone methylation, histone phosphorylation, DNA methylation, and nucleosome assembly were strongly activated in 305R but not in 372S, indicating an epigenetic-related defense mechanism.

Conclusions: Those NBS-ARC genes that were suggested to contribute to Pc5.1 in previous publications did not show any significant response in P. capsici infection and there were no significant differences of these genes in transcription levels between 305R and 372S.

 

Other pathogen defense-related genes like SN1 might account for Pc5.1. Our study also proposed the important role of sugar and epigenetic regulation in the defense against P. capsici.

 

Bioinformatics analysis and identification of genes and molecular pathways in steroid-induced osteonecrosis of the femoral head

 

Background: Steroid-induced osteonecrosis of the femoral head (ONFH) is a common hip joint disease and is difficult to be diagnosed early. At present, the pathogenesis of steroid-induced ONFH remains unclear, and recognized and effective diagnostic biomarkers are deficient. The present study aimed to identify potentially important genes and signaling pathways involved in steroid-induced ONFH and investigate their molecular mechanisms.

 

Methods: Microarray data sets GSE123568 (peripheral blood) and GSE74089 (cartilage) were obtained from the Gene Expression Omnibus database, including 34 ONFH samples and 14 control samples. Morpheus software and Venn diagram were used to identify DEGs and co-expressed DEGs, respectively. Besides, we conducted Kyoto Encyclopedia of Genome (KEGG) and gene ontology (GO) pathway enrichment analysis.

We construct a protein-protein interaction (PPI) network through GEO2R and used cytoHubba to divide the PPI network into multiple sub-networks. Additionally, quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the bioinformatics analysis results.

Results: A total of 118 intersecting DEGs were obtained between the peripheral blood and cartilage samples, including 40 upregulated genes and 78 downregulated genes. Then, GO and KEGG pathway enrichment analysis revealed that upregulated DEGs focused on the signaling pathways related to staphylococcus aureus infection, leishmaniasis, antigen processing, and presentation, as well as asthma and graft-versus-host disease.

Downregulated genes were concentrated in the FoxO signaling pathway, AMPK signaling pathway, signaling pathway regulating stem cell pluripotency, and mTOR signaling pathway. Some hub genes with high interactions such as CXCR1, FPR1, MAPK1, FOXO3, FPR2, CXCR2, and TYROBP were identified in the PPI network.

The results of qRT-PCR demonstrated that CXCR1, FPR1, and TYROBP were upregulated while MAPK1 was downregulated in peripheral blood of steroid-induced ONFH patients. This was consistent with the bioinformatics analysis.

Conclusions: The present study would provide novel insight into the genes and associated pathways involved in steroid-induced ONFH. CXCR1, FPR1, TYROBP, and MAPK1 may be used as potential drug targets and biomarkers for the diagnosis and prognosis of steroid-induced ONFH.

Cultural Evolution of Genetic Heritability

Behavioral genetics and cultural evolution have both revolutionized our understanding of human behavior-largely independent of each other. Here we reconcile these two fields under a dual inheritance framework, offering a more nuanced understanding of the interaction between genes and culture.

Going beyond typical analyses of gene-environment interactions, we describe the cultural dynamics that shape these interactions by shaping the environment and population structure. A cultural evolutionary approach can explain, for example, how factors such as rates of innovation and diffusion, density of cultural sub-groups, and tolerance for behavioral diversity impact heritability estimates, thus yielding predictions for different social contexts.

• Moreover, when cumulative culture functionally overlaps with genes, genetic effects become masked, unmasked, or even reversed, and the causal effects of an identified gene become confounded with features of the cultural environment.
• The manner of confounding is specific to a particular society at a particular time, but a WEIRD (Western, educated, industrialized, rich, democratic) sampling problem obscures this boundedness.
• Cultural evolutionary dynamics are typically missing from models of gene-to-phenotype causality, hindering generalizability of genetic effects across societies and across time.
• We lay out a reconciled framework and use it to predict the ways in which heritability should differ between societies, between socioeconomic levels and other groupings within some societies but not others, and over the life course.
• An integrated cultural evolutionary behavioral genetic approach cuts through the nature-nurture debate and helps resolve controversies in topics such as IQ.

anti- NFKB1 antibody
FNab05702	FN Test	100µg	EUR 606.3
Description: Antibody raised against NFKB1

anti- NFKB1 antibody
FNab05703	FN Test	100µg	EUR 702
Description: Antibody raised against NFKB1

anti- NFKB2 antibody
FNab05705	FN Test	100µg	EUR 606.3
Description: Antibody raised against NFKB2

anti- NFKB2 antibody
FNab05706	FN Test	100µg	EUR 658.5
Description: Antibody raised against NFKB2

Human Transcription factor p65 protein (NFKB3)
1-CSB-RP039844h	Cusabio	EUR 456.00 EUR 256.80 EUR 1570.80 EUR 672.00 EUR 1047.60 EUR 314.40	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Transcription factor p65 protein(NFKB3),partial expressed in E.coli

Human Transcription factor p65 protein (NFKB3)
1-CSB-RP039874h	Cusabio	EUR 456.00 EUR 256.80 EUR 1570.80 EUR 672.00 EUR 1047.60 EUR 314.40	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Transcription factor p65 protein(NFKB3),partial expressed in E.coli

Anti-NFkB p105/p50/NFKB1 Antibody
PB9149	BosterBio	100ug/vial	EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody
PB9150	BosterBio	100ug/vial	EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody
PA1946	BosterBio	100ug/vial	EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody
PA1946-1	BosterBio	100ug/vial	EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody
PA2111	BosterBio	100ug/vial	EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody
PA2111-1	BosterBio	100ug/vial	EUR 352.8

anti- NFKB1,p105,p50-Specific antibody
FNab05704	FN Test	100µg	EUR 702
Description: Antibody raised against NFKB1,p105,p50-Specific

anti- NFKB2,p52,p100-Specific antibody
FNab05707	FN Test	100µg	EUR 658.5
Description: Antibody raised against NFKB2,p52,p100-Specific

anti- NFKBIE antibody
FNab05708	FN Test	100µg	EUR 658.5
Description: Antibody raised against NFKBIE

anti- NFKBIZ antibody
FNab05709	FN Test	100µg	EUR 606.3
Description: Antibody raised against NFKBIZ

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx255851-96tests	Abbexa	96 tests	EUR 801.6

Pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx361108-96tests	Abbexa	96 tests	EUR 990

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit
20-abx156040	Abbexa	EUR 8684.40 EUR 4626.00 EUR 1074.00	10 × 96 tests 5 × 96 tests 96 tests

Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx254289-96tests	Abbexa	96 tests	EUR 801.6

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx252815-96tests	Abbexa	96 tests	EUR 801.6

Sheep Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx364265-96tests	Abbexa	96 tests	EUR 1111.2

Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx570127-96tests	Abbexa	96 tests	EUR 801.6

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx570125-96tests	Abbexa	96 tests	EUR 801.6

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit
20-abx152945	Abbexa	EUR 7970.40 EUR 4250.40 EUR 990.00	10 × 96 tests 5 × 96 tests 96 tests

Rabbit Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx362582-96tests	Abbexa	96 tests	EUR 990

Monkey Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx359107-96tests	Abbexa	96 tests	EUR 990

Rabbit Anti-Human NFKB1 (aa 930-934) Polyclonal Antibody
CPB-1129RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB1 (aa 160-170) Polyclonal Antibody
CPB-1169RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB2 (aa 160-171) Polyclonal Antibody
CPB-1176RH	Creative Diagnostics	100 ul	EUR 552

Chicken Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx357192-96tests	Abbexa	96 tests	EUR 990

Guinea pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit
abx357262-96tests	Abbexa	96 tests	EUR 990

Rabbit Anti-Human NFKB2 Polyclonal Antibody, aa.864-868
CPB-930RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB2 Polyclonal Antibody, aa.868-872
CPB-931RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.335-339
CPB-932RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.891-895
CPB-933RH	Creative Diagnostics	100 ul	EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.905-909
CPB-934RH	Creative Diagnostics	100 ul	EUR 552

NFKB1 antibody
10R-11003	Fitzgerald	100 ug	EUR 418.8
Description: Mouse monoclonal NFKB1 antibody

NFKB1 antibody
10R-11155	Fitzgerald	100 ug	EUR 418.8
Description: Mouse Monoclonal NFKB1 antibody

NFKB2 antibody
10R-1605	Fitzgerald	100 ug	EUR 614.4
Description: Mouse monoclonal NFKB2 antibody

NFKB1 antibody
20-PR03	Fitzgerald	100 ul	EUR 682.8
Description: Rabbit polyclonal NFKB1 antibody

NFKB2 antibody
38583-100ul	SAB	100ul	EUR 302.4

NFKB2 Antibody
37182-100ul	SAB	100ul	EUR 302.4

NFKB1 antibody
39087-100ul	SAB	100ul	EUR 302.4

NFKB1 Antibody
BF0466	Affbiotech	200ul	EUR 540

NFKB1 antibody
70R-10525	Fitzgerald	50 ug	EUR 560.4
Description: Affinity purified rabbit polyclonal NFKB1 antibody

NFKB1 antibody
70R-18860	Fitzgerald	50 ul	EUR 522
Description: Rabbit polyclonal NFKB1 antibody

NFKB2 antibody
70R-18861	Fitzgerald	50 ul	EUR 522
Description: Rabbit polyclonal NFKB2 antibody

NFKB1 antibody
70R-15433	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 Antibody
35588-100ul	SAB	100ul	EUR 302.4

NFKB2 Antibody
ABD7190	Lifescience Market	100 ug	EUR 525.6

NFKB2 Antibody
1-CSB-PA003428	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.IF:1/200-1/1000.ELISA:1/20000

NFKB2 Antibody
1-CSB-PA003429	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

NFKB1 Antibody
1-CSB-PA003430	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/10000

NFKB1 Antibody
1-CSB-PA003431	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody
1-CSB-PA003434	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody
1-CSB-PA004763	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

NFKB1 Antibody
1-CSB-PA10354A0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, ChIP; Recommended dilution: WB:1:500-1:5000, IHC:1:100-1:500, IF:1:50-1:500

NFKB2 Antibody
1-CSB-PA10449A0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

NFKB1 Antibody
1-CSB-PA259078	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:5-1:20

NFKB2 Antibody
1-CSB-PA821156	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:10000, WB:1:1000-1:5000

NFKB2 Antibody
1-CSB-PA785439	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50

NFKB2 Antibody
1-CSB-PA015760GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB1 Antibody
1-CSB-PA020085	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody
1-CSB-PA020086	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000

NFKB1 Antibody
1-CSB-PA020090	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody
1-CSB-PA020096	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody
1-CSB-PA015759GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB1 Antibody
1-CSB-PA441503	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000

NFKB1 Antibody
1-CSB-PA546304	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:25-1:100

NFKB1 Antibody
F52441-0.4ML	NSJ Bioreagents	0.4 ml	EUR 330.65
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody
F54028-0.1ML	NSJ Bioreagents	0.1 ml	EUR 322.15
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. [UniProt]

NFKB1 Antibody
F47079-0.4ML	NSJ Bioreagents	0.4 ml	EUR 322.15
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

NFKB2 Antibody
F47541-0.4ML	NSJ Bioreagents	0.4 ml	EUR 322.15
Description: NF-kappa-B has been detected in numerous cell types that express cytokines, chemokines, growth factors, cell adhesion molecules, and some acute phase proteins in health and in various disease states. NF-kappa-B is activated by a wide variety of stimuli, such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. Inappropriate activation of NF-kappa-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and AIDS. In contrast, complete and persistent inhibition of NF-kappa-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth. NFKB1 (MIM 164011) and NFKB2 encode p105 and p100 proteins that are processed to produce the active p50 and p52 NF-kappa-B subunits, respectively. However, the p100 and p105 proteins serve regulatory functions and should not be considered exclusively as precursor forms. The most abundant activated form of NF-kappa-B is a heterodimer of the p50 or p52 subunit bound to the RELA subunit (MIM 164014). Other NF-kappa-B complexes, consisting of hetero- and homodimers of p50, p52, RELA, REL (MIM 164910), and RELB (MIM 604758), have also been detected. NF-kappa-B complexes are inhibited by I-kappa-B proteins, NFKBIA (MIM 164008) or NFKBIB (MIM 604495), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by the kinases IKBKA (CHUK; MIM 600664) or IKBKB (MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. The activated NF-kappa-B complex translocates into the nucleus and binds DNA at kappa-B-binding motifs, such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine). For reviews, see Chen et al. (1999) [PubMed 9895331] and Baldwin (1996) [PubMed 8717528].

NFKB1 Antibody
R20321-0.1ML	NSJ Bioreagents	100ul	EUR 347.65
Description: This antibody reacts to human nuclear factor-kappa-B p105 subunit and p50 subunit.

NFKB2 Antibody
R31047	NSJ Bioreagents	100 ug	EUR 356.15
Description: Nuclear Factor Kappa-B, Subunit 2, also known as NFKB or p52/p100 subunit, is a protein that in humans is encoded by the NFKB2 gene. Liptay et al.(1992) mapped the gene for what they called the p49/p100 subunit of NFKB to chromosome 10 by Southern blot analysis of panels of human/Chinese hamster cell hybrids. By fluorescence in situ hybridization(FISH), they confirmed the localization and mapped the gene with greater resolution to 10q24. NFKB2 appears to be the same as LYT10. Claudio et al.(2002) showed that bone marrow(BM) cells from Nfkb2-deficient mice, but not Nfkb1-deficient mice, failed to increase relative and total IgD-positive transitional-1(T1) stage B cells in response to Baff. In vivo, however, Nfkb2-deficient mice did generate mature B cells, but at reduced numbers. Mice of the aly/aly strain, which are naturally deficient in Nik, and mice of the A/WySNJ strain, which have a mutation in Baffr, also failed to produce T1 B cells in response to Baff. Baff stimulation enhanced expression of Bcl2 in T1 B cells, thereby promoting B-cell survival, and caused the processing of the p100 form of the protein to p52, which again required Baffr and Nik, but not Nemo(IKKG). Immunoblot analysis showed that BM cells contained primarily p100.

NFKB1 Antibody
R31224	NSJ Bioreagents	100 ug	EUR 356.15
Description: Nuclear factor NF-kappa-B p105/p50, also called EBP-1 is a protein that in humans is encoded by the NFKB1 gene. By fluorescence in situ hybridization, the gene was assigned to human chromosome 4q24. NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing.

NFKB2 Antibody
R31570	NSJ Bioreagents	100 ug	EUR 356.15
Description: Nuclear factor kappa-B subunit 2 is a protein that in humans is encoded by the NFKB2 gene. It is mapped to 10q24.32. This gene encodes a subunit of the transcription factor complex nuclear factor-kappa-B (NFKB). NFKB is activated by a wide variety of stimuli such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. The NFkB complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The protein encoded by this gene can function as both a transcriptional activator or repressor depending on its dimerization partner.

NFKB1 antibody (HRP)
60R-2109	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (HRP)

NFKB1 antibody (FITC)
60R-2110	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (FITC)

NFKB1 Antibody (p105)
F52441-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody (p105)
F47079-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

Anti-IKB beta/NFKBIB Antibody
PB9292	BosterBio	100ug/vial	EUR 400.8

NFKB1 Antibody NF-kB p105/p50
R31223	NSJ Bioreagents	100 ug	EUR 356.15
Description: NF-kappa-B p105/p50, also called EBP-1 is a protein that in humans is encoded by the NFKB1 gene. By fluorescence in situ hybridization, the gene was assigned to human chromosome 4q24. NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing.

NFKB1 antibody (biotin)
60R-2111	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (biotin)

Anti-IKB alpha/NFKBIA Antibody
PB9291	BosterBio	100ug/vial	EUR 400.8

Rabbit Anti-Human NFKB1 Polyclonal Antibody, Phospho-Ser932
CPB-782RH	Creative Diagnostics	100 ul	EUR 670.8

Rabbit Anti-Human NFKB1 Polyclonal Antibody, Phospho-Ser927
CPB-827RH	Creative Diagnostics	100 ul	EUR 670.8

NFKB2 (p100) Antibody
F47541-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: NF-kappa-B has been detected in numerous cell types that express cytokines, chemokines, growth factors, cell adhesion molecules, and some acute phase proteins in health and in various disease states. NF-kappa-B is activated by a wide variety of stimuli, such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. Inappropriate activation of NF-kappa-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and AIDS. In contrast, complete and persistent inhibition of NF-kappa-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth. NFKB1 (MIM 164011) and NFKB2 encode p105 and p100 proteins that are processed to produce the active p50 and p52 NF-kappa-B subunits, respectively. However, the p100 and p105 proteins serve regulatory functions and should not be considered exclusively as precursor forms. The most abundant activated form of NF-kappa-B is a heterodimer of the p50 or p52 subunit bound to the RELA subunit (MIM 164014). Other NF-kappa-B complexes, consisting of hetero- and homodimers of p50, p52, RELA, REL (MIM 164910), and RELB (MIM 604758), have also been detected. NF-kappa-B complexes are inhibited by I-kappa-B proteins, NFKBIA (MIM 164008) or NFKBIB (MIM 604495), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by the kinases IKBKA (CHUK; MIM 600664) or IKBKB (MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. The activated NF-kappa-B complex translocates into the nucleus and binds DNA at kappa-B-binding motifs, such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine). For reviews, see Chen et al. (1999) [PubMed 9895331] and Baldwin (1996) [PubMed 8717528].

NFKB1p105 Antibody
35587-100ul	SAB	100ul	EUR 302.4

NFKB2 (pS872) Antibody
abx333034-100ul	Abbexa	100 ul	EUR 560.4

NFKB1 (pS337) Antibody
20-abx000177	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB1 (pS927) Antibody
20-abx000315	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB1 (pS893) Antibody
20-abx000462	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB1 (pS907) Antibody
20-abx000463	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB1 (pS932) Antibody
20-abx000464	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB2 (pS866) Antibody
20-abx000465	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB2 (pS870) Antibody
20-abx000466	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

NFKB1 Antibody, HRP conjugated
1-CSB-PA10354B0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

NFKB2 Antibody, HRP conjugated
1-CSB-PA10449B0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Polyclonal NFKB1 Antibody (S932)
APR04474G	Leading Biology	0.1ml	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NFKB1 (S932). This antibody is tested and proven to work in the following applications:

NFKB1 Antibody, FITC conjugated
1-CSB-PA10354C0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NFKB2 Antibody, FITC conjugated
1-CSB-PA10449C0Rb	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NFKB2 (Ab-870) Antibody
CSB-PA178291-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB2 (Ab-870). Recognizes NFKB2 (Ab-870) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB2 (Ab-870) Antibody
CSB-PA178291-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB2 (Ab-870). Recognizes NFKB2 (Ab-870) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-337) Antibody
CSB-PA186775-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-337). Recognizes NFKB1 (Ab-337) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-337) Antibody
CSB-PA186775-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-337). Recognizes NFKB1 (Ab-337) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-932) Antibody
CSB-PA190132-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-932). Recognizes NFKB1 (Ab-932) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-932) Antibody
CSB-PA190132-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-932). Recognizes NFKB1 (Ab-932) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-893) Antibody
CSB-PA108426-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-893). Recognizes NFKB1 (Ab-893) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-893) Antibody
CSB-PA108426-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-893). Recognizes NFKB1 (Ab-893) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB2 (Ab-872) Antibody
CSB-PA274947-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB2 (Ab-872). Recognizes NFKB2 (Ab-872) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

NFKB2 (Ab-872) Antibody
CSB-PA274947-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB2 (Ab-872). Recognizes NFKB2 (Ab-872) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

NFKB1 (Ab-907) Antibody
CSB-PA696291-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-907). Recognizes NFKB1 (Ab-907) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-907) Antibody
CSB-PA696291-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-907). Recognizes NFKB1 (Ab-907) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB2 (Ab-866) Antibody
CSB-PA000249-	Cusabio	each	EUR 402
Description: A polyclonal antibody against NFKB2 (Ab-866). Recognizes NFKB2 (Ab-866) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

NFKB2 (Ab-866) Antibody
CSB-PA000249-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against NFKB2 (Ab-866). Recognizes NFKB2 (Ab-866) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

Antibody for Human NFKB1
SPC-1303D	Stressmarq	0.1ml	EUR 376.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is unconjugated.

Antibody for Human NFKB1
SPC-1303D-A390	Stressmarq	0.1ml	EUR 433.2
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 390.

Antibody for Human NFKB1
SPC-1303D-A488	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 488.

Antibody for Human NFKB1
SPC-1303D-A565	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 565.

Antibody for Human NFKB1
SPC-1303D-A594	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 594.

Antibody for Human NFKB1
SPC-1303D-A633	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 633.

Antibody for Human NFKB1
SPC-1303D-A655	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 655.

Antibody for Human NFKB1
SPC-1303D-A680	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 680.

Antibody for Human NFKB1
SPC-1303D-A700	Stressmarq	0.1ml	EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 700.

Antibody for Human NFKB1
SPC-1303D-ALP	Stressmarq	0.1ml	EUR 426
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Alkaline Phosphatase.

Antibody for Human NFKB1
SPC-1303D-APC	Stressmarq	0.1ml	EUR 430.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to APC .

Antibody for Human NFKB1
SPC-1303D-APCCY7	Stressmarq	0.1ml	EUR 518.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to APC/Cy7.

Antibody for Human NFKB1
SPC-1303D-BI	Stressmarq	0.1ml	EUR 428.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Biotin.

Antibody for Human NFKB1
SPC-1303D-DY350	Stressmarq	0.1ml	EUR 523.2
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 350.

Antibody for Human NFKB1
SPC-1303D-DY405	Stressmarq	0.1ml	EUR 494.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 405.

Antibody for Human NFKB1
SPC-1303D-DY488	Stressmarq	0.1ml	EUR 471.6
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 488.